Bacterin International Holdings Inc  

(Public, OTCMKTS:BONE)   Watch this stock  
Find more results for NYSEAMEX:BONE
-0.18 (-4.86%)
Jul 31 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 3.43 - 3.85
52 week 2.19 - 7.20
Open 3.43
Vol / Avg. 8,622.00/22,690.00
Mkt cap 26.79M
P/E     -
Div/yield     -
EPS -1.55
Shares 7.04M
Beta 2.15
Inst. own 20%
Jul 28, 2015
Bacterin International Holdings Inc to Purchase the Outstanding Common Stock of X-spine Systems, Inc., Creating Xtant Medical - Webcast
Jul 9, 2015
Q2 2015 Bacterin International Holdings Inc Earnings Release
Jun 24, 2015
Bacterin International Holdings Inc Annual Shareholders Meeting
May 6, 2015
Q1 2015 Bacterin International Holdings Inc Earnings Call
May 5, 2015
Q1 2015 Bacterin International Holdings Inc Earnings Release

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin -43.95% -29.74%
Operating margin -18.23% -17.73%
EBITD margin - -12.45%
Return on average assets -60.53% -36.98%
Return on average equity - -
Employees 150 -
CDP Score - -


600 Cruiser Lane
United States - Map
+1-406-3880480 (Phone)

Website links


Bacterin International Holdings, Inc. (Bacterin), formerly K-Kitz, Inc. is a tissue bank and medical device company that designs, processes, manufactures and markets advanced medical products. Its bone graft products are used in a variety of applications including enhancing fusion in spine surgery, relief of back pain through facet joint stabilization, promotion of bone growth in foot and ankle surgery, promotion of skull healing following neurosurgery and subchondral bone repair in knee and other joint surgeries. Its acellular dermis scaffolds are utilized in wound care and plastic and reconstructive procedures. Its medical devices division develops coatings for medical devices and custom surgical instruments for use with allografts processed by its biologics division, to produce and distribute OsteoSelect DBM putty, an osteoinductive product. Its biologics products are OsteoSponge, OsteoSponge SC, OsteoWrap, OsteoLock, BacFast HD, OsteoSTX and hMatrix.

Officers and directors

Kent L. Swanson Independent Chairman of the Board
Age: 70
Robert Di Silvio President
Age: 61
Daniel S. Goldberger Chief Executive Officer, Director
Age: 56
John P. Gandolfo Chief Financial Officer
Age: 54
Darrel Lee Holmes Chief Operating Officer
Age: 62
Gregory Juda Ph.D. Chief Scientific Officer
Age: 39
John Deedrick Independent Director
Age: 52
David E. Goodman M.D. Independent Director
Age: 59
Michael A. Lopach CPA Independent Director
Age: 66
Jon M. Wickwire Independent Director
Age: 71